NEOPLASEDYL Trademark

Trademark Overview

On Monday, November 2, 2009, a trademark application was filed for NEOPLASEDYL with the United States Patent and Trademark Office. The USPTO has given the NEOPLASEDYL trademark a serial number of 77863157. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 4, 2021. This trademark is owned by Buck Mountain Botanicals, Inc.. The NEOPLASEDYL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in veterinary medicine, namely, preparations for use in the treatment of cancer
neoplasedyl

General Information

Serial Number77863157
Word MarkNEOPLASEDYL
Filing DateMonday, November 2, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 4, 2021
Registration Number3871453
Registration DateTuesday, November 2, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in veterinary medicine, namely, preparations for use in the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 4, 2021
Primary Code005
First Use Anywhere DateMonday, April 30, 2007
First Use In Commerce DateMonday, April 30, 2007

Trademark Owner History

Party NameBuck Mountain Botanicals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiles City, MT 59301
Party NameBuck Mountain Botanicals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiles City, MT 59301
Party NameBuck Mountain Botanicals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiles City, MT 59301

Trademark Events

Event DateEvent Description
Friday, June 4, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, November 2, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, March 3, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, March 3, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 3, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 29, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 2, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, September 29, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 28, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, September 27, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 24, 2010STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 25, 2010USE AMENDMENT FILED
Friday, September 24, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 25, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, July 6, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 11, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2010PUBLISHED FOR OPPOSITION
Friday, April 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 2, 2010ASSIGNED TO LIE
Wednesday, March 17, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 17, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 17, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 17, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 10, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 10, 2010NON-FINAL ACTION E-MAILED
Wednesday, February 10, 2010NON-FINAL ACTION WRITTEN
Friday, February 5, 2010ASSIGNED TO EXAMINER
Tuesday, November 10, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 5, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

neoplasedyl preparations treatment cancer namely medicine veterinary pharmaceutical